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ABSTRACT
Objective: To measure functional gait improvements of
robotic-assisted locomotion training in children with
cerebral palsy (CP).
Design: Single-case experimental A-B design.
Settings: Rehabilitation Centre Affoltern am Albis,
Children’s University Hospital Zurich, Switzerland (inpa-
tient group) and Neurology Department of the Dr von
Haunersches Children’s Hospital Munich, Germany (out-
patient group).
Participants: 22 children (mean age 8.6 years, range
4.6–11.7) with CP and a Gross Motor Function
Classification System level II to IV.
Interventions: 3 to 5 sessions of 45–60 minutes/week
during a 3–5-week period of driven gait orthosis training.
Main outcome measures: 10-metre walk test
(10MWT), 6-minute walk test (6MinWT), Gross Motor
Function Measure (GMFM-66) dimension D (standing) and
dimension E (walking), and Functional Ambulation
Categories (FAC).
Results: The mean (SD) maximum gait speed (0.78
(0.57) to 0.91 (0.61) m/s; p,0.01) as well as the mean
(SD) dimension D of the GMFM-66 (40.3% (31.3%) to
46.6% (28.7%); p,0.05) improved significantly after the
intervention period. The mean (SD) 6MinWT (176.3
(141.8) to 199.5 (157.7) m), the mean FAC (2.6 (1.7) to
3.0 (1.6)) and the mean (SD) dimension E of the GMFM-
66 (29.5% (30.3%) to 31.6% (29.2%)) also showed an
increase, but did not reach a statistically significant level.
Conclusion: These results suggest that children with CP
benefit from robotic-assisted gait training in improving
functional gait parameters.
Cerebral palsy (CP) is currently defined as a group
of non-progressive, permanent disorders which
affect movement and posture that are attributed
to disturbances occurring in the developing fetal or
infant brain.1 The incidence of CP in Europe is 2–3
per 1000 live births.2 CP is the most frequent cause
of motor, sensory and cognitive disability in
childhood.3 4 The main symptoms of CP are
weakness, spasticity and its sequelae, deformities
and contractures. Treatment options include non-
surgical therapies such as physiotherapy, occupa-
tional therapy, hippotherapy, orthotics/casting
and postural management and oral, regional or
focally administered medications as well as ortho-
paedic and neurosurgical procedures.5
In recent years, authors have increasingly placed
emphasis on promoting active therapies, including
intensive, repetitive and task-specific training to
enhance neuroplasticity.6 7 There is increasing
evidence that intensive functional training is
effective in improving the motor abilities and
muscle strength of children with CP. However,
task-specific aspects of the training and its out-
come have rarely been investigated in this popula-
tion.8 9 In adult patients with stroke, body weight-
supported treadmill training (BWSTT) has been
proven to be effective in several level I studies.10
There is also an increasing body of evidence that
BWSTT improves walking ability, speed and endur-
ance in children with mild-to-moderate CP.11–13
Based on the motor learning concept, robotic-
assisted treadmill training conducted on a driven
gait orthosis (DGO) was developed for adults in
2000.14 15 DGO training in comparison with con-
ventional over ground training (COGT) and
BWSTT offers an increase in specific gait rehabi-
litation by a greater amount of stepping practice
due to lower personal effort and costs, increased
speed and longer walking distance during therapy
sessions.16 Because the parameters of each training
session, including mileage, speed, step counts,
guidance forces and body weight support, are well
defined and continuously logged, gait training
becomes easily comparable between different
individuals and even different training settings.
This, in turn, provides new opportunities not only
for research but also for specific treatment plan-
ning and patient instructions. DGO training has
What is already known on this topic
c Driven gait orthosis training is a feasible
treatment option in children with central gait
impairment.
c Specific gait training with body weight-
supported treadmill training improves certain
gait parameters and gross motor function.
What this study adds
c Driven gait orthosis training offers a promising
treatment option for improvement of walking
abilities in children with cerebral palsy.
c The implementation of patient adaptive control
strategies and an adapted biofeedback system
for children will be crucial factors to assure
active participation.
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been found effective in improving walking abilities in adult
patients with stroke and spinal cord injury (SCI).17–19 Recently,
robotic-assisted locomotion training has been introduced and
found to be a feasible and promising therapeutic option in the
paediatric setting as well.20 21
The aim of the current study was to examine the hypothesis
that specific gait training on the DGO improves functional
walking parameters in children with chronic gait impairment
due to bilateral spastic CP.
METHODS
Participants
Patients were recruited from an inpatient setting (Rehabilitation
Centre Affoltern am Albis, University Children’s Hospital Zurich,
Switzerland) and an outpatient setting (Department of Paediatric
Neurology and Developmental Medicine of the Dr von
Haunersches Children’s Hospital, University Munich, Germany).
Children with a diagnosis of bilateral spastic CP attributed to
complications of prematurity, intracranial haemorrhage and
periventricular leucomalacia according to the definition of Bax
were enrolled in the study.22 Of all the children with CP who had
DGO training on the LokomatH during 2006–2007 in the two
centres, only those patients aged 4 to 12 years without additional
treatment with Botulinum toxin or surgery within 3 months
before onset of the LokomatH training programme were included.
Achieving or improving the ability to walk had to be a realistic goal
of the rehabilitation programme for these children. For this reason,
only children with Gross Motor Function Classification System
(GMFCS) levels II to IV were included. Femur length had to be at
least 21 cm, which correlates to children at approximately 4 years
of age. Patients had to be able to signal pain, fear or discomfort
reliably.
Exclusion criteria were severe lower extremity contractures,
fractures, osseous instabilities, osteoporosis, severe dispropor-
tional bone growth, unhealed skin lesions in the lower
extremities, thromboembolic diseases, cardiovascular instability
and aggressive or self-harming behaviours. Mild scoliosis (Cobb
angle ,20u) was not considered as an exclusion criterion.
Approval for the study was obtained from the local ethics
committees and written consent was obtained from the
parents.
Apparatus
Driven gait orthosis (LokomatH)
Robotic-assisted locomotion training was performed using the
commercially available DGO LokomatH. For children with
femur length ,35 cm the therapy was performed on the
paediatric module of the LokomatH; for larger children the adult
module was used (fig 1). The DGO consists of two exoskeletons
which are adjustable to the anthropomorphy of the patient.
Several braces are used to fasten the patient to the DGO. The
legs of the DGO are connected to the frame of a body-weight
support system by a four-bar linkage, which allows vertical
movements and provides vertical stability. On each leg, two
linear drives move the hip and knee joints of the orthosis. These
drives are position controlled so that a kinematics — resembling
a normal walking pattern — can be performed and synchronised
with the treadmill. Walking speed can be set between 1.0 and
3.2 km/h. For body-weight support, a counter system with a
harness is used. Several security measures provide safe training
conditions. These include stop buttons for both therapist and
patient, and a controller that limits both excessive force at the
drives and deviations from the desired position of the joint
angles, so that the DGO stops immediately if severe spasticity
or dystonia occurs.14
Intervention
Specific locomotion training on the DGO LokomatH was the
main intervention for the children participating in the study.
We strove for a total of 20 sessions of 45 minutes over a
4–5-week course on the DGO in the inpatient setting and for 12
sessions of 60 minutes over a 3–4-week course in the outpatient
setting. In the inpatient group, additional therapeutic sessions
of physiotherapy, speech therapy, occupational therapy and
hippotherapy were individually scheduled according to the
needs of each child. In the outpatient group, no further
therapeutic sessions were scheduled.
Outcome measures
Maximum gait speed was assessed with the 10-metre walk test
(10MWT) and gait endurance with the 6-minute walk test
(6MinWT).23 24 During pre- and postintervention assessments
children wore their usual orthoses and footwear and utilised
their regular walking aids.
Furthermore, the dimensions D (standing) and E (walking,
running, jumping) of the Gross Motor Function Measure
(GMFM-66) were assessed by GMFM-certified therapists. The
GMFM-66 is a standardised observational instrument with good
psychometric properties, categorising the 66 test items into five
developmental dimensions to measure gross motor function in
children with CP and other central disabilities.25 26 Additionally,
Functional Ambulation Categories (FAC) were collected before
and at the end of the training cycle to gather information about
the amount of walking assistance each required.27
Effective training time (minutes), walking distance (m) and
mean walking velocity (m/s) of each session were logged by the
LokomatH system.
Statistical analyses
Because the assumptions of parametric statistical analyses were
not satisfied, non-parametric test procedures were used. To
assess differences between pre- and post-tests, the changes of all
outcome parameters were analysed with Wilcoxon signed-rank
tests. Additionally, the relative changes of gait speed and
6MinWT were calculated. To account for the differences
concerning adjunctive therapies between the in- and the
outpatient group, Mann–Whitney U tests were performed. To
look for correlations between GMFCS level and training
volume, Spearman’s rank correlation (rs) coefficient was
calculated. A two-tailed level of significance was set at p,0.05
for all analyses, which were conducted using SPSS Version 15.0.
RESULTS
From the total of 67 children with CP who took part in DGO
training during 2006–2007 in the two centres, 22 children (13
males, 9 females) with a GMFCS level II to IV and without
additional treatment with Botulinum toxin or surgery within
3 months before start of the LokomatH training programme,
were included for data analysis. Eleven children and adolescents
(mean (SD) age 9.7 (1.7) years, range 6.0–11.7 years) were from
the inpatient (Zurich) setting and 11 patients (mean (SD) age
7.5 (2.0) years, range 4.6–10.9 years) were from the outpatient
setting (Munich). Eighteen children utilised walking aids and/or
orthoses on a regular basis in their daily lives. Further
characteristics of the patients are listed in table 1.
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In a mean (SD) of 15.1 (4.1) training sessions, patients walked
a mean (SD) of 842 (291) m during a mean (SD) of 31.5
(7.1) minutes per session on the DGO. Individual details of the
gait training data and of the outcome parameters are shown in
tables 2 and 3.
The assessed outcome parameters improved in the entire
study group as follows:
Mean (SD) maximum gait speed assessed with the 10MWT
improved 0.12 (0.17) m/s from 0.78 to 0.91 m/s (Z =22.856;
p,0.01), signifying a relative increase of 15.9% (fig 2A).
The covered distance in the 6MinWT improved from mean
(SD) 176.3 (141.8) m to 199.5 (157.7) m, representing a 13.1%
increase, but this gain did not reach statistical significance
(Z =21.678; p = 0.093) (fig 2B).
The scores of the standing section (D) of the GMFM
increased significantly by 6.3% from mean (SD) 40.3%
(31.3%) to 46.6% (28.7%); Z =22.475; p,0.05. The walking
section (E) showed a non-significant improvement of 2.1% from
mean (SD) 29.5% (30.3%) to 31.6% (29.2%); Z =21.376;
p = 0.169 (fig 2C).
The mean (SD) score of the FAC as a measure of the amount
of necessary walking assistance increased from 2.6 (1.7) to 3.0
(1.6) (Z =21.857; p = 0.063).
The mean training distance on the DGO correlated moder-
ately with the GMFCS level (rs =20.69; p,0.001) which
signifies that children with a lesser impairment level could
cover more distance during a training period than children with
greater impairment levels.
Between-group analyses did not reveal any significant
differences between the results of the inpatient group and the
outpatient group.
DISCUSSION
Cortical reorganisation enhanced by task-specific training is
known to be related to the intensity and frequency of training.28
Due to its ability to increase intensity and frequency, while
maintaining a physiological gait pattern, DGO training offers
nearly ideal conditions for a specific gait training.
This trial aimed to determine the functional gait improve-
ments of a specific locomotion training programme in children
and adolescents with CP performed on a DGO. The results of
the 10MWT yielded a greater than 15% increase of gait speed.
The standing dimension of the GMFM-66 improved by 6%,
although this dimension is comprised of tasks that were not
specifically trained during the intervention period.
Two controlled studies of specific gait training on BWSTT in
ambulatory children with CP have recently been conducted by
Dodd et al and Cherng et al, which showed distinct improve-
ments in gait parameters.12 13 The participants (n = 7) of Dodd’s
trial underwent a 12 BWSTT-session programme during
6 weeks. Cherng’s participants (n = 8) attended a 12-week
programme including two to three sessions per week of BWSTT
in addition to their regular therapeutic exercise programme.
Training parameters such as walking velocity and time
walked per session are considerably higher during robotic-
assisted treadmill training than can be achieved with BWSTT.
The trainings lasted 20 minutes or less in both of the studies
noted above, whereas the patients in our study reached a mean
training duration of 31.5 minutes. Manpower requirements
should also be taken into consideration, as they are often
partially responsible for limited implementation of neuro-
rehabilitative methods being put into practice.29 30 For robotic-
assisted treadmill training, only one therapist is usually
necessary, whereas at least two are needed to ensure a
physiological gait pattern in BWSTT. Though the LokomatH
indirectly allows drawing conclusions about the activity of the
patient during the training, it does not react if the child’s
participation decreases. This may explain the lack of superior
results compared with the BWSTT studies, despite longer
training sessions in our trial. However, as study designs varied
substantially among the present studies, further conclusions
cannot be extrapolated.
Wang et al have stated in their study on responsiveness of the
GMFM that an increase of 3.7% would be clinically mean-
ingful.31 Whereas dimension D of the GMFM showed a
significant increase of 6.3%, dimension E improved just 2.1%
Figure 1 Robotic-assisted locomotion training of a 12-year-old girl with
cerebral palsy on the driven gait orthosis (LokomatH).
Table 1 Clinical characteristics of the 22 participants
Mean (SD) age (years) 8.6 (2.1)
Sex (n)
Female 9
Male 13
Mean (SD) height (cm) 122.5 (14.0)
Mean (SD) weight (kg) 26.0 (9.0)
Type of CP (n)
Diplegic 10
Tetraplegic 12
GMFCS level (n)
II 5
III 13
IV 4
Walking aids (n)
Walker 9
Quad cane 3
Guided 3
None 7
Orthoses (n)
FO 1
AFO 4
HKAFO 1
None 16
DGO type (n)
CM 19
AM 3
AFO, ankle–foot orthosis; AM, adult module; CM, child module; CP,
cerebral palsy; DGO, driven gait orthosis; FO, foot orthosis; GMFCS,
Gross Motor Function Classification System; HKAFO, hip–knee–
ankle–foot orthosis.
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without statistical significance. Previous results have shown
that the walking dimension (E) in the GMFM was superior to
changes in the standing dimension (D), which may emphasise
the task-oriented specificity of the DGO training.20
Interestingly, this finding was not replicated in this study.
This observation may be somewhat surprising, because the
dimension E was specifically trained during the intervention
period. A possible explanation could be the fact that 18 of the 22
children utilised walking aids on a regular basis. However, the
GMFM was administered without walking aids, making an
improvement upon the initial score more difficult, especially in
this dimension. The 15.9% improvement in gait speed could be
Table 2 Individual training data
Patient no Group*
GMFCS
level
Number of
training
sessions
Mean
walking
distance (m)
Total
walking
distance
(km)
Mean
walking
time (min)
Total
walking
time (min)
Mean
walking
velocity
(m/s)
1 1 3 18 546 9.8 21.0 398.5 0.41
2 1 3 9 796 7.2 26.5 238.9 0.50
3 1 3 19 510 9.7 21.0 399.5 0.40
4 1 2 19 1000 19.0 30.4 577.4 0.55
5 1 3 19 844 16.0 35.2 669.3 0.40
6 1 3 21 683 14.3 28.1 590.4 0.40
7 1 3 18 397 7.1 22.9 411.3 0.29
8 1 4 22 656 14.4 30.7 674.7 0.36
9 1 3 17 951 16.2 31.2 530.7 0.51
10 1 4 20 394 7.9 25.7 513.8 0.26
11 1 3 20 870 17.4 31.6 632.0 0.46
12 2 3 12 1080 13.0 38.8 465.0 0.46
13 2 4 12 472 5.7 21.1 253.2 0.37
14 2 3 11 970 11.6 36.5 401.5 0.44
15 2 2 12 1463 17.6 43.8 525.0 0.56
16 2 2 12 1130 13.6 36.6 439.2 0.51
17 2 4 12 551 6.6 25.0 300.0 0.37
18 2 4 12 1190 14.3 41.2 493.8 0.48
19 2 2 12 1249 15.0 43.3 519.0 0.48
20 2 3 12 942 11.3 35.3 423.0 0.45
21 2 3 12 849 10.2 31.0 372.0 0.46
22 2 3 12 990 11.9 35.4 424.2 0.47
*1: inpatient, 2: outpatient.
GMFCS, Gross Motor Function Classification System.
Table 3 Individual outcome parameters
Patient no
Gait speed
pre (m/s)
Gait speed
post (m/s)
6MinWT
pre (m)
6MinWT
post (m)
GMFM D
pre (%
value)
GMFM D
post (%
value)
GMFM E
pre (%
value)
GMFM E
post (%
value)
1 ND ND ND ND 12.82 35.90 2.78 16.67
2 1.2 1.3 386 444 79.49 79.49 84.72 87.50
3 ND ND ND 104 7.69 38.46 2.78 22.22
4 2.1 2.1 370 350 87.18 87.18 84.72 87.50
5 0.6 0.7 136 164 7.69 2.56 5.56 0.00
6 1.0 1.2 ND 184 56.41 56.41 19.44 22.22
7 ND ND 102 61 20.51 38.46 4.17 6.94
8 ND ND ND ND 2.56 7.69 0.00 2.78
9 ND ND ND ND 15.38 15.38 11.11 15.28
10 ND ND 90 120 7.69 7.69 1.39 1.39
11 ND ND 48 76 12.82 15.38 1.39 6.94
12 0.1 0.1 22 36 41.03 69.23 16.67 19.44
13 0.1 0.2 ND ND 7.69 12.82 6.94 6.94
14 0.4 0.7 ND ND 15.38 33.30 22.20 22.20
15 1.4 1.5 ND ND 76.90 82.00 75.00 77.70
16 1.1 1.3 ND ND 66.60 69.20 50.00 51.38
17 0.1 0.1 34 46 5.13 7.69 4.17 0.00
18 1.1 1.8 256 420 89.74 76.92 69.44 59.72
19 0.7 0.7 140 150 48.72 48.72 19.44 22.22
20 1.3 1.4 240 280 74.36 76.92 56.94 66.67
21 0.1 0.2 42 59 35.90 38.46 19.44 19.44
22 0.3 0.3 58 59 48.72 61.54 19.44 23.61
D, standing dimension; E, walking, running, jumping dimension; GMFM, Gross Motor Function Measure; 6MinWT, 6-minute walk
test; ND, no data.
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quite meaningful with regards to a child’s participation in the
community and interaction with peers, especially when walking
short distances, such as changing between classrooms at school.
We are aware of several limitations of the present study. First,
no control group was included and no baseline period was
established, which makes it impossible to compare the described
results to the natural course of children with CP within this
time period. However, we do not expect a child with CP to
improve in functional gait parameters noticeably within 3 to
5 weeks without therapy. The sample size was small, which
may have reduced the power of this study. Even so, it is the
largest sample of children with CP studied so far regarding
either robotic-assisted or conventional BWSTT. Further, the
outcome assessors were not blinded to the pre- and post-
training condition. Only children aged 4–12 years were included
in the study. We are aware that this selection criterion was
arbitrary, but we wanted to prevent the biomechanical impact
of the pubertal growth spurt. The in- and outpatient groups
differed slightly from each other regarding the therapy protocol.
DGO training for children with CP may be an effective new
therapy option to improve gait function, because the length of
gait therapy can be increased thereby possibly enhancing neural
reorganisation.
As stated earlier by Koenig et al32 and as observed again during
this study period, the implementation of patient adaptive
control strategies and an adapted biofeedback system for
children will be crucial factors to assure maximum participation
in young children. Current projects aim to expand the existing
biofeedback system of the LokomatH, integrating technologies
with walking in a virtual reality-based environment.32 The
potential benefit of these technologies as well as the effects of
the DGO training and the optimal training parameters need to
be further investigated in particular with controlled and
randomised clinical trials and greater numbers of participants.
For this reason, taking the comparability of DGO training into
account, an international database (PeLoBASE) has been
established to enhance international collaboration.
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